Trademark: 88879903
Word
AVEYABEC
Status
Dead
Status Code
602
Status Date
Wednesday, September 8, 2021
Serial Number
88879903
Mark Type
4000
Filing Date
Monday, April 20, 2020
Abandoned Date
Tuesday, July 27, 2021

Trademark Owner History

Classifications
5 Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapy, namely T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use

Trademark Events
Sep 8, 2021
Abandonment Notice E-Mailed - Failure To Respond
Sep 8, 2021
Abandonment - Failure To Respond Or Late Response
Jan 26, 2021
Notification Of Final Refusal Emailed
Jan 26, 2021
Final Refusal E-Mailed
Jan 26, 2021
Final Refusal Written
Jan 12, 2021
Teas/Email Correspondence Entered
Jan 11, 2021
Correspondence Received In Law Office
Jan 11, 2021
Teas Response To Office Action Received
Jul 14, 2020
Notification Of Non-Final Action E-Mailed
Jul 14, 2020
Non-Final Action E-Mailed
Jul 14, 2020
Non-Final Action Written
Jul 11, 2020
Assigned To Examiner
Apr 29, 2020
New Application Office Supplied Data Entered In Tram
Apr 23, 2020
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24